CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
-4.69%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.7B
AUM Growth
+$14.7B
(-6.2%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
1.1%
Top 10 Holdings %
Top 10 Hldgs %
23.64%
Holding
885
New
75
Increased
357
Reduced
295
Closed
67
Top Buys
| 1 |
Walt Disney
DIS
|
$85.6M |
| 2 |
Merck
MRK
|
$72.8M |
| 3 |
Adobe
ADBE
|
$52.2M |
| 4 |
Booking.com
BKNG
|
$34.7M |
| 5 |
ServiceNow
NOW
|
$30.1M |
Top Sells
| 1 |
Amgen
AMGN
|
$54M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$44.5M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$36.4M |
| 4 |
Salesforce
CRM
|
$36.2M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$30.1M |
Sector Composition
| 1 | Healthcare | 29.36% |
| 2 | Technology | 26.37% |
| 3 | Financials | 8.78% |
| 4 | Communication Services | 7.86% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
PepsiCo
PEP
$203B
| $27.1M | 0.18% |
162,033
-975
| -0.6% | -$163K |
|
127
Elevance Health
ELV
$72.4B
| $27.1M | 0.18% |
55,157
+615
| +1% | +$302K |
|
128
NextEra Energy, Inc.
NEE
$148B
| $27.1M | 0.18% |
319,461
+88,321
| +38% | +$7.48M |
|
129
Invitation Homes
INVH
$18.5B
| $27M | 0.18% |
671,707
-49,934
| -7% | -$2.01M |
|
|
GBT
130
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $26.2M | 0.18% |
756,708
+108,369
| +17% | +$3.75M |
|
131
Ecopetrol
EC
$18.6B
| $25.8M | 0.18% |
+1,389,000
| New | +$25.8M |
|
132
Power Integrations
POWI
$2.46B
| $25.7M | 0.17% |
276,881
-26,183
| -9% | -$2.43M |
|
133
Micron Technology
MU
$133B
| $25.6M | 0.17% |
329,107
+257,950
| +363% | +$20.1M |
|
134
SolarEdge
SEDG
$1.97B
| $25.1M | 0.17% |
78,003
-13,937
| -15% | -$4.49M |
|
135
Synchrony
SYF
$28.1B
| $24.7M | 0.17% |
708,905
+191,144
| +37% | +$6.65M |
|
136
Mettler-Toledo International
MTD
$26.1B
| $24.5M | 0.17% |
17,840
-802
| -4% | -$1.1M |
|
137
Xylem
XYL
$34B
| $24.4M | 0.17% |
286,702
-63,204
| -18% | -$5.39M |
|
138
McCormick & Company Non-Voting
MKC
$18.7B
| $24.3M | 0.17% |
243,407
-15,299
| -6% | -$1.53M |
|
139
Ambarella
AMBA
$3.36B
| $24.3M | 0.17% |
231,352
+31,255
| +16% | +$3.28M |
|
140
Crown Castle
CCI
$42.3B
| $23.9M | 0.16% |
129,391
-61,953
| -32% | -$11.4M |
|
141
Apellis Pharmaceuticals
APLS
$3.51B
| $23.7M | 0.16% |
466,095
-228,330
| -33% | -$11.6M |
|
142
West Pharmaceutical
WST
$17.9B
| $23.7M | 0.16% |
57,606
-2,833
| -5% | -$1.16M |
|
|
ATVI
143
DELISTED
Activision Blizzard Inc.
ATVI
| $23.6M | 0.16% |
295,104
-11,840
| -4% | -$948K |
|
144
Cytokinetics
CYTK
$5.98B
| $23.6M | 0.16% |
640,228
+126,884
| +25% | +$4.67M |
|
145
Xencor
XNCR
$594M
| $23.4M | 0.16% |
876,981
+45,642
| +5% | +$1.22M |
|
146
Colgate-Palmolive
CL
$67.7B
| $23.4M | 0.16% |
308,528
+27,680
| +10% | +$2.1M |
|
147
Schlumberger
SLB
$52.2B
| $23.2M | 0.16% |
562,695
+425,980
| +312% | +$17.6M |
|
148
Keros Therapeutics
KROS
$638M
| $22.9M | 0.16% |
420,670
+179,724
| +75% | +$9.77M |
|
149
EOG Resources
EOG
$65.8B
| $22.8M | 0.15% |
190,945
+161,275
| +544% | +$19.2M |
|
150
Sherwin-Williams
SHW
$90.5B
| $22.8M | 0.15% |
91,169
+74,859
| +459% | +$18.7M |
|